Furthermore, cancer cell-derived growth factors upregulated one of the VLA-4 ligands, namely, extracellular matrix fibronectin, in resident fibroblasts, thereby providing a permissive niche for incoming tumor cells. This evidence concerns the gene FN1 and neoplasm.